title: The impact of liquid-based cytology in decreasing the incidence of cervical cancer.
abstract: Major advances in screening have lowered the death rate from cervical cancer in the United States. One of the first major advances in cervical cancer screening was the Papanicolaou (Pap) test. The second major advance was liquid-based cytology (LBC). This review presents a wide range of data, discusses the strengths and weaknesses of the available information regarding Pap technologies, and reviews the meta-analyses, which have examined the differences in clinical performance. The review concludes with information on new and future developments to further decrease cervical cancer deaths.
authors: Randall K
authors: RK
authors: Gibb
authors: Mark G
authors: MG
authors: Martens
references: J Natl Cancer Inst. 2008 Apr 2;100(7):513-7
references: 18364507
references: Diagn Cytopathol. 2000 Jul;23(1):19-22
references: 10907926
references: Obstet Gynecol. 1997 Aug;90(2):278-84
references: 9241308
references: Cancer. 1999 Apr 25;87(2):48-55
references: 10227593
references: J Natl Cancer Inst. 2005 Jul 20;97(14):1072-9
references: 16030305
references: Arch Intern Med. 2010 Jun 14;170(11):985-6
references: 20548012
references: Diagn Cytopathol. 2007 Apr;35(4):213-7
references: 17351933
references: Cancer. 2002 Dec 25;96(6):338-43
references: 12478681
references: Cancer Epidemiol Biomarkers Prev. 2008 Apr;17(4):810-7
references: 18398022
references: Obstet Gynecol. 2008 Jan;111(1):167-77
references: 18165406
references: Med Decis Making. 2010 Jan-Feb;30(1):84-98
references: 19525483
references: Br J Cancer. 2001 Jun 15;84(12):1616-23
references: 11401314
references: Ann Intern Med. 2000 May 16;132(10):810-9
references: 10819705
references: Int J Cancer. 2007 Aug 1;121(3):621-32
references: 17405118
references: Am J Clin Pathol. 2009 Nov;132(5):767-75
references: 19846820
references: Lancet. 2006 Jan 14;367(9505):122-32
references: 16413876
references: N Engl J Med. 2007 Oct 18;357(16):1579-88
references: 17942871
references: Cancer. 1999 Jun 25;87(3):105-12
references: 10385440
references: Arch Pathol Lab Med. 1997 Mar;121(3):211-24
references: 9111103
references: BMJ. 2009 Jul 28;339:b2569
references: 19638649
references: Int J Cancer. 2004 Aug 20;111(2):278-85
references: 15197783
references: JAMA. 2002 May 8;287(18):2372-81
references: 11988058
references: BMJ. 2007 Jul 7;335(7609):31
references: 17604301
references: N Engl J Med. 1996 Apr 18;334(16):1030-8
references: 8598842
references: J Low Genit Tract Dis. 2004 Oct;8(4):308-12
references: 15874878
references: Acta Cytol. 1999 Jan-Feb;43(1):81-5
references: 9987455
references: Obstet Gynecol. 2008 Dec;112(6):1419-1444
references: 19037054
references: Acta Cytol. 2002 May-Jun;46(3):453-7
references: 12040636
references: Am J Obstet Gynecol. 2001 Aug;185(2):308-17
references: 11518884
references: Arch Pathol Lab Med. 1999 Sep;123(9):817-21
references: 10458830
references: Int J Cancer. 1978 Apr 15;21(4):418-25
references: 669847
references: Gynecol Oncol. 2010 Aug 1;118(2):116-22
references: 20488510
references: Cancer. 2003 Oct 25;99(5):263-71
references: 14579292
references: JAMA. 2002 Apr 24;287(16):2114-9
references: 11966386
references: Cancer. 2004 Oct 25;102(5):269-79
references: 15386329
references: J Reprod Med. 2001 Apr;46(4):353-8
references: 11354836
references: Arch Pathol Lab Med. 2010 Mar;134(3):331-5
references: 20196659
references: Gynecol Oncol. 2003 Jul;90(1):137-44
references: 12821354
references: J Natl Cancer Inst. 2001 Feb 21;93(4):293-9
references: 11181776
references: Obstet Gynecol. 2010 Nov;116(5):1158-70
references: 20966702
references: J Infect Dis. 2006 Nov 1;194(9):1291-9
references: 17041856
references: Am J Obstet Gynecol. 1992 Apr;166(4):1254-9
references: 1566781
references: Diagn Cytopathol. 2000 Oct;23(4):260-5
references: 11002368
references: Diagn Cytopathol. 2008 Mar;36(3):155-60
references: 18232005